A Case Report: Massive Spontaneous Hemorrhage of Neurofibromatosis Type 1 on Upper Back

Case Report

Austin J Surg. 2022; 9(2): 1287.

A Case Report: Massive Spontaneous Hemorrhage of Neurofibromatosis Type 1 on Upper Back

Yeh CC*

Division of Plastic Surgery, Department of Surgery, Chi-Mei Medical Center, Taiwan

*Corresponding author: Chin-Choon Yeh, Division of Plastic Surgery, Department of Surgery, Chi-Mei Medical Center, Yong-Kang Distinct, Tainan City, Taiwan

Received: July 07, 2022; Accepted: August 05, 2022; Published: August 12, 2022

Abstract

Neurofibromatosis type 1 (NF1) (von Recklinghausen’s disease) is an autosomal dominant disorder characterized by café-au-lait spots, pigmented hamartomas of the iris, and multiple neurofibromas. Patients can present with hemorrhage secondary to trauma or rarely with spontaneous hemorrhage.

We report a 42-year-old man with long-term history of a giant neurofibroma on his back who suffered from spontaneous hemorrhage. Series examinations and treatments were given to stop bleeding and eventually to heal the wound.

Keywords: Neurofibromatosis type 1; Spontaneous hemorrhage

Introduction

Neurofibromatosis ype 1 (NF1), also called as von Recklinghausen’s disease, usually involves organs of ectodermal oringin. It is an autosomal dominant disease having an incidence of 1 in 3000 individuals. It primarily involves the peripheral nervous system and usually presents with many neurofibromas [1]. Cutaneous neurofibromas are hallmarks of Neurofibromatosis type 1 (NF1) and cause the main disease burden in adults with NF1 [2]. People suffering from neurofibromatosis face various challenges in their daily activities, including spontaneous rupture and hemorrhage especially on large-sized lesions.

Case Report

A 42-year-old man has history of neurofibromatosis type 1 for more than 30 years was admitted to the hospital due to an emergent episode of massive spontaneous hemorrhage inside a giant neurofibroma on the left side upper back. The patient had a left upper back neurofibroma with size about 6 cm for long time, and then it got enlargement to 14x8-cm within 6 hours. There were no traumas or fierce exercise before the episode. On physical examination, it revealed that patient was of short stature with severe scoliosis, and displayed diffuse cafe-au-lait spot on the skin, plexiform neurofibroma on the back. There was a 14x8-cm hematoma originating from neurofibroma on the left side back (Figure 1). Local tenderness and 5x3 cm skin erosion on neurofibroma were also found (Figure 2). Tachycardia with acceptable blood pressure were recorded. Trunk CT showed that at left scapula area, a hematoma with considering active bleeding from left thoracodorsal artery was favored (Figure 3). At emergency room, hematoma compression with bandage, fluid resuscitation and pain control with analgesics were managed. 4 hours later however, dizziness, unstable systolic blood pressure, increasing back hematoma size (from 14x8-cm to 20 x 18- cm), hemoglobin level progressive decrease (from 137 g/L to 84 g/L) occurred. Urgent angiographic embolization was performed to stop the bleeding. During left subclavian arteriography, it proved that the large hematoma was truly supplying by branch of left thoracodorsal artery. Major feeder was embolized with gel-foam pieces and a 0.018/14cm/4mm coil (Figure 4). The patient’s hemodynamic condition stabilized gradually. 4 days after admission, severe sepsis due to neurofibroma wound skin necrosis causing soft tissue infection was noted (Figure 5). Clinical condition subsided after systemic antibiotics administration. 11 days after admission, the hematoma and neurofibroma were surgically resected, with 1800 gm hematoma and some active bleeder from latissimus dorsi muscle seen during operation (Figure 6). In spite upper back sutured wound had partial skin necrosis post-operatively, regular wound care with Neomycin containing ointment was applied. The wound healed day by day. The patient was discharged 20 days after the operation. There was no recurrence of neurofibroma or hematoma at 3-month follow-up (Figure 7).